Diet and weight loss as a treatment for psoriasis

Archives of Dermatology

Volumn 146, Issue 5, 2010, Pages 544-546

  Gelfand, Joel M ^a   Abuabara, Katrina ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN;

BODY MASS; BODY SURFACE; CALORIC RESTRICTION; CHRONIC DISEASE; DISEASE SEVERITY; DRUG WITHDRAWAL; EXERCISE; FOLLOW UP; HUMAN; ITALY; LOW CALORY DIET; LOW DRUG DOSE; NOTE; OBESITY; OUTPATIENT DEPARTMENT; PRIORITY JOURNAL; PSORIASIS VULGARIS; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT; WEIGHT REDUCTION;

EID: 77952607080     PISSN: 0003987X     EISSN: 15383652     Source Type: Journal    
DOI: 10.1001/archdermatol.2010.92     Document Type: Note

References (21)

1. Azfar RS, Gelfand JM. Psoriasis and metabolic disease: epidemiology and pathophysiology. Curr Opin Rheumatol. 2008;20(4):416-422.
2. Huerta C, Rivero E, Rodriguez LA. Incidence and risk factors for psoriasis in the general population. Arch Dermatol. 2007;143(12):1559-1565. (Pubitemid 350277774)
3. Neimann AL, Shin DB, Wang X, Margolis DJ, Troxel AB, Gelfand JM. Prevalence of cardiovascular risk factors in patients with psoriasis. J Am Acad Dermatol. 2006;55(5):829-835. (Pubitemid 44556851)
4. Setty AR, Curhan G, Choi HK. Obesity, waist circumference, weight change, and the risk of psoriasis in women: Nurses' Health Study II. Arch Intern Med. 2007; 167(15):1670-1675. (Pubitemid 47280349)
5. de Menezes Ettinger JE, Azaro E, de Souza CA, et al. Remission of psoriasis after open gastric bypass. Obes Surg. 2006;16(1):94-97. (Pubitemid 43232247)
6. Higa-Sansone G, Szomstein S, Soto F, Brasecsco O, Cohen C, Rosenthal RJ. Psoriasis remission after laparoscopic Roux-en-Y gastric bypass for morbid obesity. Obes Surg. 2004;14(8):1132-1134. (Pubitemid 39299743)
7. Guyatt G, Rennie D, Meade MO, Cook DJ, eds. Users' Guides to the Medical Literature: A Manual for Evidence-Based Clinical Practice. 2nd ed. New York, NY: McGraw-Hill; 2008. http://www.jamaevidence.com/content/3345000. Accessed March 10, 2010.
8. Pintadosi S. Clinical Trials: A Methodologic Perspective. New York, NY: John Wiley and Sons; 1997.
9. Behnam SM, Behnam SE, Koo JY. Alcohol as a risk factor for plaque-type psoriasis. Cutis. 2005;76(3):181-185. (Pubitemid 41413664)
10. Rucević I, Perl A, Barisic-Drusko V, Adam-Perl M. The role of the low energy diet in psoriasis vulgaris treatment. Coll Antropol. 2003;27(suppl 1):41-48. (Pubitemid 38340151)
11. Wolters M. Diet and psoriasis: experimental data and clinical evidence. Br J Dermatol. 2005;153(4):706-714. (Pubitemid 41415895)
12. Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials. 1996;17(1):1-12. (Pubitemid 26120810)
13. Brimhall AK, King LN, Licciardone JC, Jacobe H, Menter A. Safety and efficacy of alefacept, efalizumab, etanercept and infliximab in treating moderate to severe plaque psoriasis: a meta-analysis of randomized controlled trials. Br J Dermatol. 2008;159(2):274-285.
14. Dansinger ML, Tatsioni A, Wong JB, Chung M, Balk EM. Meta-analysis: the effect of dietary counseling for weight loss. Ann Intern Med. 2007;147(1):41-50.
15. Tsai AG, Wadden TA. Systematic review: an evaluation of major commercial weight loss programs in the United States. Ann Intern Med. 2005;142(1):56-66.
16. Friedewald VE, Cather JC, Gelfand JM, et al. AJC editor's consensus: psoriasis and coronary artery disease. Am J Cardiol. 2008;102(12):1631-1643.
17. Gelfand JM, Dommasch ED, Shin DB, et al. The risk of stroke in patients with psoriasis. J Invest Dermatol. 2009;129(10):2327.
18. Gelfand JM, Neimann AL, Shin DB, Wang X, Margolis DJ, Troxel AB. Risk of myocardial infarction in patients with psoriasis. JAMA. 2006;296(14):1735-1741. (Pubitemid 44547793)
19. Gelfand JM, Troxel AB, Lewis JD, et al. The risk of mortality in patients with psoriasis4results from a population-based study. Arch Dermatol. 2007;143(12): 1493-1499.
20. Kimball AB, Gladman D, Gelfand JM, et al; National Psoriasis Foundation. National Psoriasis Foundation clinical consensus on psoriasis comorbidities and recommendations for screening. J Am Acad Dermatol. 2008;58(6):1031-1042.
21. Mehta NN, Azfar RS, Shin DB, Neimann AL, Troxel AB, Gelfand JM. Patients with severe psoriasis are at increased risk of cardiovascular mortality: cohort study using the General Practice Research Database [published online December 27, 2009]. Eur Heart J. doi: 10.1093/eurheartj/ehp567.